In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013

BACKGROUND: Artemisinin-based combination therapy (ACT) is the recommended first-line treatment of falciparum malaria in all endemic countries. Artemisinin resistance in Plasmodium falciparum has been confirmed in the Greater Mekong subregion (GMS). Dihydroartemisinin-piperaquine (DAPQ) is the most...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Malar J
Autors principals: Liu, Hui, Yang, Heng-lin, Tang, Lin-hua, Li, Xing-liang, Huang, Fang, Wang, Jia-zhi, Li, Chun-fu, Wang, Heng-ye, Nie, Ren-hua, Guo, Xiang-rui, Lin, Ying-xue, Li, Mei, Wang, Jian, Xu, Jian-wei
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4333884/
https://ncbi.nlm.nih.gov/pubmed/25652213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-015-0584-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars